The relationship between DLAT expression and tumor grade was investigated with the UALCAN, with the result that DLAT expressions varied with the tumor grades in several tumors, including KIRC, brain lower grade glioma (LGG), LIHC, ovarian serous cystadenocarcinoma (OV), pancreatic adenocarcinoma (PAAD) and STAD (Figs. 1E–1J). This evidence concerns the gene DLAT and neoplasm.